141 related articles for article (PubMed ID: 11302696)
1. Transient expression of wild-type or biologically inactive telomerase allows the formation of artificial telomeres in mortal human cells.
Guiducci C; Anglana M; Wang A; Bacchetti S
Exp Cell Res; 2001 May; 265(2):304-11. PubMed ID: 11302696
[TBL] [Abstract][Full Text] [Related]
2. Telomere dynamics in cells with introduced telomerase: a rapid assay for telomerase activity on telomeres.
McChesney PA; Aisner DL; Frank BC; Wright WE; Shay JW
Mol Cell Biol Res Commun; 2000 May; 3(5):312-8. PubMed ID: 10964756
[TBL] [Abstract][Full Text] [Related]
3. Maintenance of telomeres in SV40-transformed pre-immortal and immortal human fibroblasts.
Small MB; Hubbard K; Pardinas JR; Marcus AM; Dhanaraj SN; Sethi KA
J Cell Physiol; 1996 Sep; 168(3):727-36. PubMed ID: 8816928
[TBL] [Abstract][Full Text] [Related]
4. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells.
Goldkorn A; Blackburn EH
Cancer Res; 2006 Jun; 66(11):5763-71. PubMed ID: 16740715
[TBL] [Abstract][Full Text] [Related]
5. Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells.
Sachsinger J; González-Suárez E; Samper E; Heicappell R; Müller M; Blasco MA
Cancer Res; 2001 Jul; 61(14):5580-6. PubMed ID: 11454711
[TBL] [Abstract][Full Text] [Related]
6. Immortal ALT+ human cells do not require telomerase reverse transcriptase for malignant transformation.
Sun B; Chen M; Hawks CL; Hornsby PJ
Cancer Res; 2005 Aug; 65(15):6512-5. PubMed ID: 16061628
[TBL] [Abstract][Full Text] [Related]
7. Strict control of telomerase activation using Cre-mediated inversion.
Ungrin MD; Harrington L
BMC Biotechnol; 2006 Feb; 6():10. PubMed ID: 16504006
[TBL] [Abstract][Full Text] [Related]
8. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
9. Amplification of telomerase reverse transcriptase gene in human mammary epithelial cells with limiting telomerase RNA expression levels.
Cao Y; Huschtscha LI; Nouwens AS; Pickett HA; Neumann AA; Chang AC; Toouli CD; Bryan TM; Reddel RR
Cancer Res; 2008 May; 68(9):3115-23. PubMed ID: 18451136
[TBL] [Abstract][Full Text] [Related]
10. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
[TBL] [Abstract][Full Text] [Related]
11. Telomere length homeostasis requires that telomerase levels are limiting.
Cristofari G; Lingner J
EMBO J; 2006 Feb; 25(3):565-74. PubMed ID: 16424902
[TBL] [Abstract][Full Text] [Related]
12. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.
Fasching CL; Bower K; Reddel RR
Cancer Res; 2005 Apr; 65(7):2722-9. PubMed ID: 15805271
[TBL] [Abstract][Full Text] [Related]
13. Telomere dynamics, end-to-end fusions and telomerase activation during the human fibroblast immortalization process.
Ducray C; Pommier JP; Martins L; Boussin FD; Sabatier L
Oncogene; 1999 Jul; 18(29):4211-23. PubMed ID: 10435634
[TBL] [Abstract][Full Text] [Related]
14. Comparison of human mammary epithelial cells immortalized by simian virus 40 T-Antigen or by the telomerase catalytic subunit.
Toouli CD; Huschtscha LI; Neumann AA; Noble JR; Colgin LM; Hukku B; Reddel RR
Oncogene; 2002 Jan; 21(1):128-39. PubMed ID: 11791183
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.
Yang G; Rosen DG; Mercado-Uribe I; Colacino JA; Mills GB; Bast RC; Zhou C; Liu J
Carcinogenesis; 2007 Jan; 28(1):174-82. PubMed ID: 16829690
[TBL] [Abstract][Full Text] [Related]
16. A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT.
Cerone MA; Autexier C; Londoño-Vallejo JA; Bacchetti S
Oncogene; 2005 Nov; 24(53):7893-901. PubMed ID: 16116482
[TBL] [Abstract][Full Text] [Related]
17. Telomeric function of mammalian telomerases at short telomeres.
Fakhoury J; Marie-Egyptienne DT; Londoño-Vallejo JA; Autexier C
J Cell Sci; 2010 May; 123(Pt 10):1693-704. PubMed ID: 20427319
[TBL] [Abstract][Full Text] [Related]
18. Telomerase inhibition in a mouse cell line with long telomeres leads to rapid telomerase reactivation.
Marie-Egyptienne DT; Brault ME; Zhu S; Autexier C
Exp Cell Res; 2008 Feb; 314(3):668-75. PubMed ID: 18067891
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms.
Horikawa I; Barrett JC
Carcinogenesis; 2003 Jul; 24(7):1167-76. PubMed ID: 12807729
[TBL] [Abstract][Full Text] [Related]
20. Aneuploidy and telomere attrition are independent determinants of crisis in SV40-transformed epithelial cells.
Velicescu M; Yu J; Herbert BS; Shay JW; Granada E; Dubeau L
Cancer Res; 2003 Sep; 63(18):5813-20. PubMed ID: 14522904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
